PDE6A
Basic information
Region (hg38): 5:149857953-149944793
Previous symbols: [ "PDEA" ]
Links
Phenotypes
GenCC
Source:
- retinitis pigmentosa (Supportive), mode of inheritance: AD
- retinitis pigmentosa 43 (Strong), mode of inheritance: AR
- retinitis pigmentosa 43 (Definitive), mode of inheritance: AR
- inherited retinal dystrophy (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Retinitis pigmentosa 43 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 7493036; 18723146; 21039428 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (42 variants)
- Retinitis pigmentosa 43 (12 variants)
- Retinitis pigmentosa (11 variants)
- Inborn genetic diseases (2 variants)
- Retinal dystrophy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE6A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 119 | 10 | 134 | |||
missense | 339 | 354 | ||||
nonsense | 21 | 28 | ||||
start loss | 1 | |||||
frameshift | 22 | 34 | ||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 16 | 24 | ||||
splice region | 19 | 27 | 2 | 48 | ||
non coding | 62 | 69 | 29 | 160 | ||
Total | 54 | 32 | 420 | 195 | 40 |
Highest pathogenic variant AF is 0.0000657
Variants in PDE6A
This is a list of pathogenic ClinVar variants found in the PDE6A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-149858006-G-C | Retinitis pigmentosa | Uncertain significance (Jan 13, 2018) | ||
5-149858042-G-C | Retinitis pigmentosa | Likely benign (Jan 12, 2018) | ||
5-149858124-C-G | Retinitis pigmentosa | Benign (Jan 12, 2018) | ||
5-149858126-T-G | Retinitis pigmentosa | Benign (Jan 12, 2018) | ||
5-149858178-C-T | Retinitis pigmentosa | Uncertain significance (Jan 12, 2018) | ||
5-149858233-T-C | Retinitis pigmentosa | Likely benign (Jan 13, 2018) | ||
5-149858253-CCATAA-C | Retinitis Pigmentosa, Recessive | Uncertain significance (Jun 14, 2016) | ||
5-149858269-G-C | Retinitis pigmentosa | Uncertain significance (Jan 13, 2018) | ||
5-149858275-G-T | Retinitis pigmentosa | Uncertain significance (Jan 13, 2018) | ||
5-149858279-C-T | Retinitis pigmentosa | Uncertain significance (Jan 13, 2018) | ||
5-149858280-G-A | Retinitis pigmentosa | Uncertain significance (Jan 13, 2018) | ||
5-149858313-A-G | Retinitis pigmentosa | Uncertain significance (Jan 12, 2018) | ||
5-149858353-C-T | Retinitis pigmentosa | Benign (Jan 13, 2018) | ||
5-149858370-T-G | Retinitis pigmentosa | Likely benign (Jan 13, 2018) | ||
5-149858434-G-A | Retinitis pigmentosa | Uncertain significance (Jan 12, 2018) | ||
5-149858495-C-T | Retinitis pigmentosa | Uncertain significance (Jan 13, 2018) | ||
5-149858512-C-T | Retinitis pigmentosa | Uncertain significance (Jan 12, 2018) | ||
5-149858559-G-A | Retinitis pigmentosa | Benign (Jan 13, 2018) | ||
5-149858666-G-A | Retinitis pigmentosa | Likely benign (Jan 12, 2018) | ||
5-149858701-C-T | Retinitis pigmentosa | Benign (Jan 13, 2018) | ||
5-149858757-C-T | Retinitis pigmentosa | Uncertain significance (Jan 13, 2018) | ||
5-149858785-T-C | Retinitis pigmentosa | Benign (Jan 12, 2018) | ||
5-149858791-AAG-A | Retinitis Pigmentosa, Recessive | Uncertain significance (Jun 14, 2016) | ||
5-149858814-ATC-A | Retinitis Pigmentosa, Recessive | Uncertain significance (Jun 14, 2016) | ||
5-149858815-TC-T | Retinitis Pigmentosa, Recessive | Uncertain significance (Jun 14, 2016) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PDE6A | protein_coding | protein_coding | ENST00000255266 | 22 | 86838 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.58e-25 | 0.00525 | 125614 | 0 | 134 | 125748 | 0.000533 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.426 | 504 | 478 | 1.05 | 0.0000283 | 5789 |
Missense in Polyphen | 238 | 217.14 | 1.0961 | 2654 | ||
Synonymous | -0.104 | 183 | 181 | 1.01 | 0.0000116 | 1506 |
Loss of Function | 0.873 | 41 | 47.5 | 0.863 | 0.00000240 | 560 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00103 | 0.00103 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00147 | 0.00147 |
Finnish | 0.000142 | 0.000139 |
European (Non-Finnish) | 0.000484 | 0.000484 |
Middle Eastern | 0.00147 | 0.00147 |
South Asian | 0.000687 | 0.000621 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: This protein participates in processes of transmission and amplification of the visual signal.;
- Disease
- DISEASE: Retinitis pigmentosa 43 (RP43) [MIM:613810]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:10393062, ECO:0000269|PubMed:7493036}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Purine metabolism - Homo sapiens (human);Phototransduction - Homo sapiens (human);Phosphodiesterases in neuronal function;Signaling by GPCR;Signaling by WNT;Signal Transduction;visual signal transduction;Purine metabolism;Purine nucleotides nucleosides metabolism;Ca2+ pathway;Beta-catenin independent WNT signaling;Visual signal transduction: Rods;G alpha (i) signalling events;Activation of the phototransduction cascade;Inactivation, recovery and regulation of the phototransduction cascade;The phototransduction cascade;Visual phototransduction;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.202
Intolerance Scores
- loftool
- 0.543
- rvis_EVS
- -0.19
- rvis_percentile_EVS
- 39.31
Haploinsufficiency Scores
- pHI
- 0.390
- hipred
- N
- hipred_score
- 0.322
- ghis
- 0.409
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.476
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pde6a
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;visual perception;rhodopsin mediated signaling pathway;regulation of rhodopsin mediated signaling pathway;regulation of cytosolic calcium ion concentration;retina development in camera-type eye
- Cellular component
- plasma membrane;photoreceptor disc membrane
- Molecular function
- metal ion binding;3',5'-cyclic-GMP phosphodiesterase activity